Molecule Details
InChIKeyZBBHBTPTTSWHBA-UHFFFAOYSA-N
Compound NameNicardipine
Canonical SMILESCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Cross-Family
Avg pChEMBL6.34
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00622
Drug NameNicardipine
CAS Number55985-32-5
Groups approved investigational
ATC Codes C08CA04
DescriptionA potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineo...

Categories: Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Agents causing hyperkalemia Agents producing tachycardia Antiarrhythmic agents Anticholinergic Agents Antihypertensive Agents Antihypertensive Agents Indicated for Hypertension BSEP/ABCB11 Substrates Bradycardia-Causing Agents Calcium Channel Blockers Calcium Channel Blockers (Dihydropyridine) Calcium-Regulating Hormones and Agents Cardiovascular Agents Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 CYP2B6 Inducers (strength unknown) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (moderate) Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2C9 Inhibitors (strong) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inhibitors Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dihydropyridine Derivatives Dihydropyridines Hypotensive Agents Membrane Transport Modulators Muscarinic Antagonists OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inhibitors P-glycoprotein substrates Potential QTc-Prolonging Agents Pyridines QTc Prolonging Agents Selective Calcium Channel Blockers With Mainly Vascular Effects Vasodilating Agents
Cross-references: BindingDB: 50101815 ChEBI: 180905 CHEMBL1484 ChemSpider: 4319 Drugs Product Database (DPD): 1293 Guide to Pharmacology: 2559 IUPHAR: 2559 C07264 PharmGKB: PA450620 PubChem:4474 PubChem:46504482 RxCUI: 7396 Therapeutic Targets Database: DAP000486 Wikipedia: Nicardipine
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
Q13936 CACNA1C Homo sapiens Human PF08763 PF16885 PF16905 PF00520 6.6 IC50 ChEMBL;BindingDB
P08684 CYP3A4 Homo sapiens Human PF00067 6.4 IC50 ChEMBL;BindingDB
P11712 CYP2C9 Homo sapiens Human PF00067 6.4 IC50 ChEMBL;BindingDB
P33261 CYP2C19 Homo sapiens Human PF00067 6.2 IC50 ChEMBL;BindingDB
P08183 ABCB1 Homo sapiens Human PF00664 PF00005 6.0 IC50 ChEMBL
DrugBank Target Actions (33)
Target Gene Target Name Action Type
P20813 CYP2B6 Cytochrome P450 2B6 inducer enzymes
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10632 CYP2C8 Cytochrome P450 2C8 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P11712 CYP2C9 Cytochrome P450 2C9 inhibitor enzymes
P20815 CYP3A5 Cytochrome P450 3A5 inhibitor enzymes
P33261 CYP2C19 Cytochrome P450 2C19 inhibitor enzymes
P05181 CYP2E1 Cytochrome P450 2E1 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10632 CYP2C8 Cytochrome P450 2C8 substrate enzymes
P08172 CHRM2 Muscarinic acetylcholine receptor M2 antagonist targets
P08173 CHRM4 Muscarinic acetylcholine receptor M4 antagonist targets
P08912 CHRM5 Muscarinic acetylcholine receptor M5 antagonist targets
P11229 CHRM1 Muscarinic acetylcholine receptor M1 antagonist targets
P20309 CHRM3 Muscarinic acetylcholine receptor M3 antagonist targets
P25100 ADRA1D Alpha-1D adrenergic receptor antagonist targets
P35348 ADRA1A Alpha-1A adrenergic receptor antagonist targets
P35368 ADRA1B Alpha-1B adrenergic receptor antagonist targets
O43497 CACNA1G Voltage-dependent T-type calcium channel subunit alpha-1G inhibitor targets
O95180 CACNA1H Voltage-dependent T-type calcium channel subunit alpha-1H inhibitor targets
P54289 CACNA2D1 Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor targets
P54750 PDE1A Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A inhibitor targets
Q01064 PDE1B Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B inhibitor targets
Q01668 CACNA1D Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor targets
Q06432 CACNG1 Voltage-dependent calcium channel inhibitor targets
Q08289 CACNB2 Voltage-dependent L-type calcium channel subunit beta-2 inhibitor targets
Q13936 CACNA1C Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor targets
Q9P0X4 CACNA1I Voltage-dependent T-type calcium channel subunit alpha-1I inhibitor targets
P0DP23 CALM1 Calmodulin other/unknown targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 inhibitor transporters
O95342 ABCB11 Bile salt export pump substrate transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters